Skip to main content
Clinical Trials/NCT03785197
NCT03785197
Unknown
N/A

Effects of a Clinical Dietary Intervention During Inpatient Treatment (Modified Fasting in Metabolic Syndrome, Osteoarthritis of the Hip or Knee, Rheumatoid Arthritis and Fibromyalgia)

Charite University, Berlin, Germany1 site in 1 country500 target enrollmentFebruary 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
Charite University, Berlin, Germany
Enrollment
500
Locations
1
Primary Endpoint
Health Assessment Questionnaire (HAQ)
Last Updated
4 years ago

Overview

Brief Summary

The purpose of the study is a scientific and prospective documentation of the clinical effects of an inpatient treatment at the Immanuel Hospital of Berlin, in the department for complementary and integrative medicine, with the use of a modified fasting regime. A pre- and post- as well as group comparisons are planned. Patients that are admitted to the inpatient department for metabolic syndrome, osteoarthritis of the hip or knee, rheumatoid arthritis and fibromyalgia will be enrolled in the study.

Detailed Description

At the beginning, during and at the end of the treatment at the inpatient department routine blood parameters, anthropometric parameters and certain scores and parameters specific to the different conditions will be measured. Questionnaires will be filled out by patients before and after the treatment as well as 3, 6 and 12 months after leaving the inpatient department.

Registry
clinicaltrials.gov
Start Date
February 1, 2018
End Date
March 1, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Andreas Michalsen

Principal Investigator

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • The patient is consents to participating in the trial during the first 24h of his or her stay in the inpatient naturopathic department of the Immanuel Hospital.
  • Written informed consent is given
  • The referral diagnosis is one of the following: diabetes mellitus type 2/metabolic syndrome, osteoarthritis of the hip, osteoarthritis of the knee, rheumatoid arthritis, fibromyalgia.

Exclusion Criteria

  • Language barries to understanding the instructions of the study personnel
  • Dementia or other strong cognitive impairment
  • Pregnant or lactating women
  • Taking part in another study at the same time

Outcomes

Primary Outcomes

Health Assessment Questionnaire (HAQ)

Time Frame: Change Baseline, 2 weeks, 3 months, 6 months, 12 months

Questionnaire; Change from Baseline in the HAQ, range from 0 to 3 while higher values meaning a higher grade of disability

Disease Activity Score 28 (DAS 28)

Time Frame: Change Baseline, 2 weeks, 3 months, 6 months, 12 months

Questionnaire with Clinical Examination; Change from Baseline in the DAS-28, range from 2.0 to 10.0 while higher values meaning a higher disease activity and below of 2.6 meaning remission

Summary of Diabetes Self Care Activities Measure (SDSCA)

Time Frame: Change Baseline, 2 weeks, 3 months, 6 months, 12 months

Questionnaire; 11 items with each item scored on a scale of 0-7.

Fibromyalgia Impact Questionnaire (FIQ)

Time Frame: Change Baseline, 2 weeks, 3 months, 6 months, 12 months

Questionnaire; The FIQ is scored in such a way that a higher score indicates a greater impact of the syndrome on the person. Each of the 10 items has a maximum possible score of 10. Thus the maximum possible score is 100. The average FM patient scores about 50, severely afflicted patients are usually 70 plus.

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

Time Frame: Change Baseline, 2 weeks, 3 months, 6 months, 12 months

Questionnaire consisting of 24 items divided into 3 subscales: Pain (5items), Stiffness (2 items), Physical Function (17 items). The test questions are scored on a scale of 0-4, which correspond to: None (0), Mild (1), Moderate (2), Severe (3), and Extreme (4). The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Higher values meaning a higher grade of disability.

Secondary Outcomes

  • Quality of Life (WHO-5)(Change Baseline, 2 weeks, 3 months, 6 months, 12 months)
  • Body-Mass-Index (BMI)(Change Baseline, 2 weeks)
  • Blood count(Change Baseline, 2 weeks)
  • Heart Rate Variability(Change Baseline, 2 weeks)
  • Heart Rate(Change Baseline, 2 weeks)
  • Blood pressure(Change Baseline, 2 weeks)
  • Glomerular filtration rate (GFR)(Change Baseline, 2 weeks)
  • CRP(Change Baseline, 2 weeks)
  • Blood lipids(Change Baseline, 2 weeks)
  • Liver enzymes (GOT, GPT)(Change Baseline, 2 weeks)
  • Stepcounter(Change Baseline, 2 weeks)
  • Blood Oxygenation(Change Baseline, 2 weeks)
  • Pain on Visual Analogue Scale (VAS)(Change Baseline, 2 weeks, 3 months, 6 months, 12 months)
  • Hospital Anxiety and Depression Scale (HADS)(Change Baseline, 2 weeks, 3 months, 6 months, 12 months)
  • Perceived Stress Scale (PSS)(Change Baseline, 2 weeks, 3 months, 6 months, 12 months)
  • 24h-Blood pressure(Change Baseline, 2 weeks)

Study Sites (1)

Loading locations...

Similar Trials